ESLA

Estrella Immunopharma (ESLA)

About Estrella Immunopharma (ESLA)

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.

Details

Daily high

$0.78

Daily low

$0.71

Price at open

$0.77

52 Week High

$3.15

52 Week Low

$0.68

Market cap

32.1M

Dividend yield

0.00%

Volume

13,933

Avg. volume

45,104

P/E ratio

-2.11

Estrella Immunopharma News